Using Clonidine to Improve Leg Weakness in People With Heart Failure

Completed · Phase 4 · Has a placebo group

Conditions studied: Heart Failure

In brief

People with heart failure often have weakness in their leg muscles. This study will determine whether the leg weakness is due to very high adrenaline levels and whether the medication clonidine can improve leg weakness.

Key facts

Study ID

NCT00858845

Run by

University of California, Los Angeles

People needed

11

Starts

2008-05-01

Expected to finish

2012-12-01

Last updated by the study team

2018-05-24

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Heart failure

You may not qualify if…

• Currently on Coumadin therapy
• Experienced a heart attack in the 3 months before study entry
• Medically unable to receive clonidine
• Advanced kidney or liver disease

Where it is running

• University of California, Los Angeles Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.